Non-Hodgkin lymphoma Clinical Trials in Morehead City, NC
As of June 2026, 1 paid clinical trial is recruiting for Non-Hodgkin lymphoma in Morehead City, North Carolina. Lymphoma research explores bispecific antibodies, CAR-T cell therapies, and new targeted agents for Hodgkin and non-Hodgkin lymphomas. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Morehead City
Filter results
1 clinical trial for Non-Hodgkin lymphoma
·Clear filters·↓ Download CSVAbout research studies in Morehead City
Morehead City has approximately 54 recruiting research studies across a wide range of therapeutic areas. North Carolina hosts Duke University Medical Center, UNC Health, and Wake Forest Baptist Health, with strong programs in oncology, cardiovascular disease, and translational research anchored by Research Triangle Park.
Top Research Study Locations in Morehead City
Researchers run research studies in Morehead City, NC at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| West Clinical Research | Alzheimer Disease, Diabetic Peripheral Neuropathic Pain, Obesity | 11 |
| Carteret Medical Group | Obesity, Chronic Kidney Disease, Heart Failure | 5 |
| Lucas Research, Inc. | Cardiovascular Diseases, Diabetes Mellitus, Type 2, Hypertension | 5 |
| Kailera Clinical Site | Obesity, Obesity With Diabetes, Overweight | 3 |
| Lucas Research, Inc | Obesity, Overweight | 3 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Centricity Rsrch MHCity Multi | Diabetes Mellitus, Type 1, Obesity, Type 2 Diabetes | 2 |
| GSK Investigational Site | Non-alcoholic Fatty Liver Disease | 2 |
| 89bio Clinical Study Site | Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis | 1 |
| Carteret General Hospital | Lumbar Spinal Stenosis | 1 |
| Carteret Health Care Cancer Center | Chronic Myeloproliferative Disorders, Cognitive/Functional Effects, Leukemia | 1 |
| Carteret Medical Group /ID# 256869 | Hypothyroidism | 1 |
| Carteret Medical Group LLC | Gout | 1 |
| Centricity Research Morehead City Multispeciality | Obesity or Overweight, Type 2 Diabetes Mellitus | 1 |
| Centricity Research Morehead City Multispecialty | Diabetes Mellitus, Type 1 | 1 |
| Centricity Research dba Lucas Research | Lipidemia, Metabolic Syndrome (MetS), Type 2 Diabetes (T2DM) | 1 |
| Crinetics Study Site | Classic Congenital Adrenal Hyperplasia, Congenital Adrenal Hyperplasia | 1 |
| Local Institution - 1215 | Psychosis Associated With Alzheimer's Disease | 1 |
| Local Institution - 5005 | Alzheimer Disease | 1 |
| Lucas Research - Diabetes & Endocrinology Consultants, PC | Chronic Idiopathic Constipation (CIC) | 1 |
| Lucas Research /ID# 256127 | Hypothyroidism | 1 |
| Lucas Research /ID# 257061 | Hypothyroidism | 1 |
| Lucas Research Inc | Cortisol Excess, Type 2 Diabetes | 1 |
| Lucas Research Inc. | Type 1 Diabetes Mellitus With Hypoglycemia | 1 |
| MBX Biosciences Investigational Site | Postbariatric Hypoglycemia | 1 |
Active & Upcoming Studies in Morehead City (2026)
Recruiting trials in Morehead City grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Diabetes & metabolic (26 active studies)
- Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus · Phase 2 · Hanmi Pharmaceutical Company Limited
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight · Phase 2 · Eli Lilly and Company
Neurology & pain (5 active studies)
- A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3) · Phase 3 · Bristol-Myers Squibb
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
Cardiovascular (3 active studies)
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease · Phase 3 · Boehringer Ingelheim
- A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure · Phase 3 · AstraZeneca
Cancer & tumors (2 active studies)
- DermaSensor Postmarket Surveillance Study · DermaSensor, Inc.
- Registry of Older Patients With Cancer · UNC Lineberger Comprehensive Cancer Center
Vaccines (1 active study)
- A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza · Phase 3 · Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Common conditions studied in Morehead City
- Obesity (10 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Overweight (8 active studies). Recruiting Overweight studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Alzheimer Disease (3 active studies). Alzheimer's research investigates anti-amyloid antibodies, tau-targeted therapies, and lifestyle interventions aimed at slowing cognitive decline.
- Type 2 Diabetes (3 active studies). Type 2 diabetes studies test GLP-1 agonists, SGLT-2 inhibitors, and combination regimens aimed at glycemic control and cardiovascular risk reduction.
- Diabetes Mellitus, Type 1 (2 active studies). Diabetes trials evaluate new insulin formulations, GLP-1 receptor agonists, continuous glucose monitoring technologies, and disease-modifying therapies.
- Diabetes Mellitus, Type 2 (2 active studies). Diabetes trials evaluate new insulin formulations, GLP-1 receptor agonists, continuous glucose monitoring technologies, and disease-modifying therapies.
Leading research sponsors in Morehead City
- Eli Lilly and Company
- AstraZeneca
- Novo Nordisk A/S
- Kailera
- Akero Therapeutics, Inc
Local regulations and guidelines
Clinical trials in North Carolina are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. North Carolina research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Morehead City. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Morehead City
Hipa.ai aggregates every recruiting study in Morehead City from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Morehead City?
There are approximately 54 recruiting clinical trials in Morehead City, North Carolina listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Morehead City pay participants?
Most recruiting trials in Morehead City compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Morehead City?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Morehead City?
The most common conditions under active study in Morehead City include Obesity (10), Overweight (8), Alzheimer Disease (3), Type 2 Diabetes (3), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Morehead City?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Morehead City on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Morehead City?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Morehead City?
Recruiting research sites in Morehead City include West Clinical Research, Carteret Medical Group, Lucas Research, Inc., among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Morehead City right now?
The largest active categories in Morehead City are Diabetes & metabolic (26), Neurology & pain (5), Cardiovascular (3). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.